Generic Fortamet Diabetes Drug Recalled for Carcinogens
Lupin Pharmaceuticals recalled a generic version of the diabetes medication Fortamet® due to high levels of a carcinogenic chemical.
Two More Companies Recall Metformin ER Diabetes Drugs for Carcinogens
Teva Pharmaceuticals and Marksans Pharma Ltd. have recalled the diabetes drug metformin after they tested positive for high levels of a cancer-causing chemical impurity.
Amneal Pharmaceuticals Recalls Metformin ER for Carcinogens
Another drug-maker has recalled extended-release metformin due to high levels of a cancer-causing chemical called NDMA.
Apotex Corp. Recalls Extended-Release Metformin for Carcinogens
Apotex Corp. recalled all lots of extended-release metformin (500-mg) after FDA tests found high levels of a cancer-causing chemical.
FDA Finds High Levels of Carcinogen in Diabetes Drug Metformin
Tests on some extended-release versions of the diabetes drug metformin found high levels of a cancer-causing chemical impurity called N-Nitrosodimethylamine (NDMA), according to the FDA.
Pharmacy Demands Metformin Recall for NDMA Carcinogens
A pharmacy is recommending recalls for the diabetes drug metformin after tests found excessive levels of a cancer-causing chemical.